Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

NSE : NGLFINEBSE : 524774ISIN CODE : INE887E01022Industry : Pharmaceuticals & DrugsHouse : Private

BSE2146.7064.4 (+3.09 %)

PREV CLOSE ( ) 2082.30

OPEN PRICE ( ) 2084.20

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 939

TODAY'S LOW / HIGH ( )2020.40 2157.25

52 WK LOW / HIGH ( )985.05 2596

NSE2132.6051.4 (+2.47 %)

PREV CLOSE( ) 2081.20

OPEN PRICE ( ) 2059.10

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 2994

TODAY'S LOW / HIGH( ) 2021.30 2149.90

52 WK LOW / HIGH ( )980 2575

Chairman	Dhananjay Mungale
Managing Director	Rahul Nachane
Company Secretary	Shivam Gharat
Independent Director	Sudhir Deo
Non Executive Independent Director	Jayaram Sitaram Sarala Menon
Whole Time Director	Rajesh Lawande
Non Independent & Non Executive Director	Ajita Nachane

Incorporation Year : 1981

Registered Office :

Address : 301 E Square,Subhash Road,Vile Parle (East) Mumbai,
Maharashtra-400057 .

Phone : 022 26636450

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE